Silver output surged quarter over quarter
Sean Mason | April 18, 2016 | SmallCapPower
Production results boosted a silver miner’s shares Monday, while there was more bad news for a beaten-down biotech play. Here’s some small stocks making big moves on Monday, April 18, 2016 (as of 4 pm EST):
Excellon Resources Inc. (TSE:EXN) shares surged 33% to $1.30 on Monday after the Mexico-focused silver miner announced that Q1 silver equivalent production from the La Platosa Mine in Mexico increased 40% quarter over quarter to 363,552 ounces.
As well, shares of Telesta Therapeutics Inc. (TSE:TST) plunged 37% to $0.085 as the biotechnology company said the FDA has ruled that any potential commercial approval of MCNA would require an additional Phase 3 clinical trial to be completed prior to resubmission of the MCNA BLA, which Telesta estimates could not be obtained for a period of at least five years and possibly longer depending on the exact clinical trial design and required patient follow-up period.
Macarthur Minerals Limited (CVE:MMS), meanwhile, reported the appointment of Emeritus Professor Ken Collerson to its newly-formed Lithium Advisory Board to support development of the Company’s hard rock lithium projects in Australia. Macarthur Minerals stock popped 86% to $0.13 following the announcement.
Finally, Primero Mining Corp. (TSE:P) shares slid 17% to $2.19 after the precious metals producer announced that it is reducing its 2016 production guidance to between 230,000 and 250,000 gold equivalent ounces at expected all-in sustaining costs of between $975 and $1,025 per gold ounce.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.
